SYNERGY 48 mm

DEVICE2 trials

Sponsors

Boston Scientific Corporation, Meshalkin Research Institute of Pathology of Circulation

Conditions

Coronary Artery DiseaseCoronary AtherosclerosisIschemic Heart Disease

Phase 3

A Clinical Trial to Assess the SYNERGY 48 mm Stent System for the Treatment of Atherosclerotic Lesion(s)

CompletedNCT03350542

Boston Scientific CorporationCoronary Artery Disease

Start: 2018-04-12End: 2021-01-08Updated: 2021-05-14

Unknown Phase

StEnt Coverage and Neointimal Tissue Characterization After eXtra Long evErolimus - Eluting Stent imPlantation

Meshalkin Research Institute of Pathology of CirculationCoronary Artery Disease, Coronary Atherosclerosis, Ischemic Heart Disease

Start: 2017-03-20End: 2019-04-30Target: 80Updated: 2018-01-17